ES2199681B1 - Una forma farmaceutica solida para piensos substancialmente granular y no pulverulenta. - Google Patents

Una forma farmaceutica solida para piensos substancialmente granular y no pulverulenta.

Info

Publication number
ES2199681B1
ES2199681B1 ES200201815A ES200201815A ES2199681B1 ES 2199681 B1 ES2199681 B1 ES 2199681B1 ES 200201815 A ES200201815 A ES 200201815A ES 200201815 A ES200201815 A ES 200201815A ES 2199681 B1 ES2199681 B1 ES 2199681B1
Authority
ES
Spain
Prior art keywords
solid pharmaceutical
pharmaceutical form
pulverulent
granular
substantially granular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200201815A
Other languages
English (en)
Other versions
ES2199681A1 (es
Inventor
Jordi Prat Aran
Gemma Fernandez Escorihuela
Marta Torras Genis
Joan Marca Puig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Calier S A Lab
LABORATORIOS CALIER SA
Original Assignee
Calier S A Lab
LABORATORIOS CALIER SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calier S A Lab, LABORATORIOS CALIER SA filed Critical Calier S A Lab
Priority to ES200201815A priority Critical patent/ES2199681B1/es
Publication of ES2199681A1 publication Critical patent/ES2199681A1/es
Application granted granted Critical
Publication of ES2199681B1 publication Critical patent/ES2199681B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/10—Shaping or working-up of animal feeding-stuffs by agglomeration; by granulation, e.g. making powders
    • A23K1/002—
    • A23K1/16—
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"Una forma farmacéutica sólida para piensos substancialmente granular y no pulverulenta". La presente invención se refiere a una forma farmacéutica sólida substancialmente granular y no pulverulenta, destinada a piensos para el tratamiento y prevención de enfermedades o la alimentación de los animales que comprende un núcleo inerte, un recubrimiento basado en ésteres grasos de alcoholes polihidroxílicos junto con al menos un principio activo, y una capa exterior protectora de parafina. Esta forma farmacéutica sólida granular exhibe una mayor estabilidad del producto y una mejor fluidez de vertido, y permite una dosificación más precisa de los principios activos en los piensos para animales.
ES200201815A 2002-08-01 2002-08-01 Una forma farmaceutica solida para piensos substancialmente granular y no pulverulenta. Expired - Fee Related ES2199681B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES200201815A ES2199681B1 (es) 2002-08-01 2002-08-01 Una forma farmaceutica solida para piensos substancialmente granular y no pulverulenta.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200201815A ES2199681B1 (es) 2002-08-01 2002-08-01 Una forma farmaceutica solida para piensos substancialmente granular y no pulverulenta.

Publications (2)

Publication Number Publication Date
ES2199681A1 ES2199681A1 (es) 2004-02-16
ES2199681B1 true ES2199681B1 (es) 2005-05-01

Family

ID=31897090

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200201815A Expired - Fee Related ES2199681B1 (es) 2002-08-01 2002-08-01 Una forma farmaceutica solida para piensos substancialmente granular y no pulverulenta.

Country Status (1)

Country Link
ES (1) ES2199681B1 (es)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016043A (en) * 1978-03-08 1979-09-19 Danochemo As Bacteria-containing product for use in animal feeds, and its production

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1185550B (it) * 1985-04-12 1987-11-12 Dox Al Italia Spa Miscele non polverose di sfarinati o farine con principi attivi per mangimistica
FR2656772B1 (fr) * 1989-12-28 1992-09-18 Rhone Poulenc Nutrition Animal Procede d'incorporation dans des pellets de principes actifs proteges contre la degradation dans la panse des ruminants.
FR2663818B1 (fr) * 1990-06-29 1993-07-09 Rhone Poulenc Nutrition Animale Procede de preparation de granules de principes actifs par extrusion.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016043A (en) * 1978-03-08 1979-09-19 Danochemo As Bacteria-containing product for use in animal feeds, and its production

Also Published As

Publication number Publication date
ES2199681A1 (es) 2004-02-16

Similar Documents

Publication Publication Date Title
PA8559501A1 (es) Formulaciones farmaceuticas de 5,7,14-triazatetraciclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaeno
PT954314E (pt) Formas de dosagem farmaceutica para melhorar a disfuncao erectil masculina
ECSP066990A (es) Formulaciones con liberación controlada de principio activo que contienen vardenafilo
UY29093A1 (es) Derivados de 4-oxo-3. 4-dihidroquinazolin-6-carboxamida, inhibidores de b-raf, composiciones que los contienen, procesos de preparación y aplicaiones.
ECSP077999A (es) Formulaciones de una sal de bupropion de liberación modificada
DE60132077D1 (de) Vitaminzusammenstellung mit verzögerter freigabe
AR060019A1 (es) Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo
PA8606201A1 (es) DERIVADOS DE PIRROLO[3,4-c) PIRAZOL ACTIVOS COMO INHIBIDORES DE QUINASA, PROCESO PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN
AR038899A1 (es) Un medicamento para animales
CR8480A (es) Formulaciones veterinarias que contienen producto no animal
SG157406A1 (en) Oral medicament for the modified release of at least one active principle, in multi-microcapsule form
AR094374A1 (es) Composiciones y métodos para el tratamiento de trastornos metabólicos
TN2010000135A1 (en) Galenical formulations of organic compounds
MX2009008084A (es) Derivados de 5,6,7,8-tetrahidropteridina como inhibidores de hsp90.
ATE505203T1 (de) Pharmazeutische kombination aus aliskiren und valsartan
PE20150773A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilefrina
BR122016006880B8 (pt) forma de dosagem contendo pantoprazol como ingrediente ativo
WO2006050002A3 (en) Compositions for controlled delivery of pharmaceutically active compounds
AR039895A1 (es) Composicion que comprende una vitamina, una sal de metal y una insulina o una hormona del crecimiento y uso de dichos componentes para prepararla
ES2199681B1 (es) Una forma farmaceutica solida para piensos substancialmente granular y no pulverulenta.
AR046213A1 (es) Forma de presentacion del naproxeno sodico
GT201000064A (es) Formulaciones galénicas de alisquireno
JO3239B1 (ar) تركيبات جالينية من مركبات عضوية
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent
AR040764A1 (es) Formulaciones farmaceuticas de epinastina, pseudoefedrina y metilefedrina

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20040216

Kind code of ref document: A1

FD2A Announcement of lapse in spain

Effective date: 20220826